Comment on

• Practice parameter: management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia.

  [No authors listed] [No authors listed] Pediatrics. 1994 Oct;94(4 Pt 1):558-65. Pediatrics. 1994. PMID: 7755691 No abstract available.
• Research on prevention of bilirubin-induced brain injury and kernicterus: National Institute of Child Health and Human Development conference executive summary. 2003.

  Blackmon LR, Fanaroff AA, Raju TN; National Institute of Child Health and Human Development. Blackmon LR, et al. Pediatrics. 2004 Jul;114(1):229-33. doi: 10.1542/peds.114.1.229. Pediatrics. 2004. PMID: 15231933 Review.
• Hyperbilirubinemia and kernicterus: 50 years later.

  Ip S, Lau J, Chung M, Kulig J, Sege R, Glicken S, O'Brien R. Ip S, et al. Pediatrics. 2004 Jul;114(1):263-4. doi: 10.1542/peds.114.1.263. Pediatrics. 2004. PMID: 15231941 No abstract available.
• Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

  American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Pediatrics. 2004 Jul;114(1):297-316. doi: 10.1542/peds.114.1.297. Pediatrics. 2004. PMID: 15231951
• An evidence-based review of important issues concerning neonatal hyperbilirubinemia.

  Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, Maisels MJ, Lau J; American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Ip S, et al. Pediatrics. 2004 Jul;114(1):e130-53. doi: 10.1542/peds.114.1.e130. Pediatrics. 2004. PMID: 15231986 Review.